In Vivo Phase Variation of Escherichia coli Type 1 Fimbrial Genes in Women with Urinary Tract Infection

ABSTRACT Type 1 fimbriae, expressed by most Escherichia colistrains, are thought to attach to human uroepithelium as an initial step in the pathogenesis of urinary tract infections (UTI). Numerous reports using both in vitro and murine models support this role for type 1 fimbriae in colonization. Unfortunately, only a limited number of studies have directly examined the expression of fimbriae in vivo. To determine whether type 1 fimbrial genes are transcribed during an acute UTI, we employed a modification of an established method. The orientation (ON or OFF) of the invertible promoter element, which drives transcription of type 1 fimbrial genes, was determined by PCR amplification using primers that flank the invertible element, followed by SnaBI digestion. The orientation of the type 1 fimbrial switch was determined under three experimental conditions. First,E. coli strains from different clinical sources (acute pyelonephritis patients, cystitis patients, and fecal controls) were tested under different in vitro culture conditions (agar versus broth; aerated versus static). The genes in the more-virulent strains (those causing acute pyelonephritis) demonstrated a resistance, in aerated broth, to switching from OFF to ON, while those in fecal strains readily switched from OFF to ON. Second, bladder and kidney tissue from CBA mice transurethrally inoculated with E. coli CFT073 (an established murine model of ascending UTI) was assayed. The switches directly amplified from infected bladder and kidney tissues were estimated to be 33 and 39% ON, respectively, by using a standard curve. Finally, bacteria present in urine samples collected from women with cystitis were tested for type 1 fimbria switch orientation. For all 11 cases, an average of only 4% of the switches in the bacteria in the urine were ON. In 7 of the 11 cases, we found that all of the visible type 1 fimbrial switches were in the OFF position (upper limit of detection of assay, 98% OFF). Strains recovered from these urine samples, however, were shown after culture in vitro to be capable of switching the fimbrial gene to the ON position and expressing mannose-sensitive hemagglutinin. The results from experimental infections and cases of cystitis in women suggest that type 1 fimbrial genes are transcribed both in the bladder and in the kidney. However, those bacteria found in the urine and not attached to the uroepithelium are not transcriptionally active for type 1 fimbrial genes.

[1]  D. Žgur-Bertok,et al.  Virulence determinants of uropathogenic Escherichia coli in fecal strains from intestinal infections and healthy individuals. , 1998, FEMS microbiology letters.

[2]  J. Hacker,et al.  The Pai‐associated leuX specific tRNALeu5 affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression , 1997, Molecular microbiology.

[3]  H. Mobley,et al.  Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains , 1997, Infection and immunity.

[4]  S. Langermann,et al.  Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.

[5]  I. Blomfield,et al.  In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract , 1997, Molecular microbiology.

[6]  J. Mecsas,et al.  Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands. , 1996, Emerging infectious diseases.

[7]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Marc,et al.  Analysis of the fim cluster of an avian O2 strain of Escherichia coli: serogroup-specific sites within fimA and nucleotide sequence of fimI. , 1996, Journal of medical microbiology.

[9]  H. Mobley,et al.  Urinary tract infections : molecular pathogenesis and clinical management , 1996 .

[10]  B. Foxman,et al.  Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection. , 1995, The Journal of infectious diseases.

[11]  A. Siitonen What makes Escherichia coli pathogenic? , 1994, Annals of medicine.

[12]  R. Russell,et al.  Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection , 1994, Infection and immunity.

[13]  K. Jarvis,et al.  Isogenic P‐fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of α Gal(1–4)β Gal binding in virulence of a wild‐type strain , 1993 .

[14]  I. Blomfield,et al.  Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media , 1993, Journal of bacteriology.

[15]  H. Mobley,et al.  Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection , 1991, Infection and immunity.

[16]  M. S. McClain,et al.  Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli , 1991, Journal of bacteriology.

[17]  J. R. Johnson,et al.  Virulence factors in Escherichia coli urinary tract infection , 1991, Clinical Microbiology Reviews.

[18]  H. Holthöfer,et al.  Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract , 1990, Infection and immunity.

[19]  H. Mobley,et al.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.

[20]  S. Mårild,et al.  Special virulence of the Escherichia coli O1:K1:H7 clone in acute pyelonephritis. , 1989, The Journal of pediatrics.

[21]  A. Schaeffer,et al.  In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections , 1989, Infection and immunity.

[22]  G. Schoolnik How Escherichia coli infects the urinary tract. , 1989 .

[23]  G. K. Schoolrik How Escherichia coli infects the urinary tract. , 1989, The New England journal of medicine.

[24]  J. Duncan Differential effect of Tamm-Horsfall protein on adherence of Escherichia coli to transitional epithelial cells. , 1988, The Journal of infectious diseases.

[25]  S. Hull,et al.  Attachment of Escherichia coli via mannose- or Gal alpha 1----4Gal beta-containing receptors to human colonic epithelial cells , 1988, Infection and immunity.

[26]  J. Parkkinen,et al.  Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins , 1988, Infection and immunity.

[27]  H. Mobley,et al.  Urease-positive bacteriuria and obstruction of long-term urinary catheters , 1987, Journal of clinical microbiology.

[28]  A. Siitonen,et al.  Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. , 1987, The Journal of infectious diseases.

[29]  A. Schaeffer,et al.  Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice , 1987, Infection and immunity.

[30]  A. Schaeffer,et al.  Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli , 1986, Infection and Immunity.

[31]  L. Maurer,et al.  Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli , 1986, Infection and immunity.

[32]  P. Klemm,et al.  Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. , 1986, The EMBO journal.

[33]  A. Schaeffer,et al.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli , 1985, Infection and immunity.

[34]  W. Simpson,et al.  Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors , 1985, Infection and immunity.

[35]  S. Falkow,et al.  Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili , 1985, Journal of bacteriology.

[36]  B. Nowicki,et al.  Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71 , 1984, Journal of bacteriology.

[37]  S. Falkow,et al.  Contribution of Adhesion to Bacterial Persistence in the Mouse Urinary Tract , 1983, Infection and immunity.

[38]  R. Freter,et al.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.

[39]  Y. Abe,et al.  Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice , 1983, Infection and immunity.

[40]  N. Sharon,et al.  Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine , 1981, Infection and immunity.

[41]  B. Eisenstein Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. , 1981, Science.

[42]  L. Hagberg,et al.  Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections , 1981, Infection and immunity.

[43]  F. Silverblatt,et al.  Antipili antibody affords protection against experimental ascending pyelonephritis. , 1979, The Journal of clinical investigation.

[44]  N. Sharon,et al.  Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. , 1979, The Journal of infectious diseases.

[45]  D. Musher,et al.  Urease. The primary cause of infection-induced urinary stones. , 1976, Investigative urology.